Head-to-head · verified 2026-08-05
Noom Med vs. PlushCare: prices, fine print, and the honest verdict
A product decision wearing a price tag: PlushCare fulfills the FDA-approved medication while the other sells compounded product — this page prices the trade instead of pretending it's one market.
- Noom Med
- Official site
- www.noom.com ↗
- Tirzepatide, all-in at 10 mg
- Not offered
- Semaglutide, all-in
- $199/mo
- Brand medications
- brand GLP-1 pathways described
- Membership fee
- None
- Commitment
- 12-week cycles
- Cancellation
- 12-week billing cycles
- Pharmacy
- Tailor Made Compounding (named)
- Price evidence
- Source-verified
- Last verified
- 2026-08-08
- PlushCare
- Official site
- plushcare.com ↗
- Tirzepatide, all-in at 10 mg
- Offered — no published price
- Semaglutide, all-in
- Offered — no published price
- Brand medications
- brand GLP-1 prescriptions to your pharmacy
- Membership fee
- None
- Commitment
- none stated
- Cancellation
- membership terms apply
- Pharmacy
- your retail pharmacy
- Price evidence
- No price published
- Last verified
- 2026-08-05
Tirzepatide pricing
Noom Med does not offer tirzepatide. PlushCare offers tirzepatide without a published price we could capture.
Semaglutide pricing
Only Noom Med publishes a semaglutide price here: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose. PlushCare offers semaglutide without a published price.
Different products, not just different prices
PlushCare fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Noom Med sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.
Transparency
Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). PlushCare: No price published (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.
Commitment & cancellation
Noom Med: 12-week cycles; 12-week billing cycles. PlushCare: none stated; membership terms apply.
Noom Med: no published price captured; PlushCare: brand fulfillment (Zepbound $299–$449 / Wegovy $349); semaglutide: Noom Med $199; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.
The semaglutide board
Only Noom Med fields a verified semaglutide price here — $199/month all-in (#None of 19) — while PlushCare routes semaglutide demand to brand Wegovy at $349 flat. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.
The five normalizations, applied to this pair
1 · All-in, not advertised. Noom Med publishes no figure to normalize; PlushCare bills at manufacturer/insurance rates plus any stated program fee. 4 · Evidence tiered. Noom Med: source-verified, read 2026-08-08; PlushCare: no price published, read 2026-08-05. 5 · Pharmacy weighed. Noom Med names Tailor Made Compounding (named); PlushCare names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.
Fine print, itemized
Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. PlushCare: no membership — the medication figure is the billed figure; membership terms apply; commitment: none stated. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.
Transparency, audited
Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. PlushCare carries no price published pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.
Switching between them
Moving from Noom Med to PlushCare (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.
Refills, shipping, and the week-to-week reality
The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Noom Med: shipping included; consultation included; async visit model. PlushCare: shipping n/a (retail pharmacy); consultation per-visit or membership; video visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.
Who should pick which
Pick Noom Med if a named pharmacy is non-negotiable for you. Pick PlushCare if only the FDA-approved product will do; you want the insurance paperwork done for you. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.
What verification would take
For PlushCare, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.
If neither one fits
The dataset's bench is deep; the closest verified third options to this matchup's price band are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.
The verdict
This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.
Quick answers
What's the real difference between Noom Med and PlushCare?
PlushCare fulfills FDA-approved brand medication; the other sells compounded product that is not FDA-reviewed. Price, product risk, and legal stability all differ.
Can I switch between them?
Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.
Which is easier to cancel, Noom Med or PlushCare?
Is there a brand alternative to both?
Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.